BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17269124)

  • 1. New computational strategy to analyze the interactions of ERalpha and ERbeta with different ERE sequences.
    Marabotti A; Colonna G; Facchiano A
    J Comput Chem; 2007 Apr; 28(6):1031-41. PubMed ID: 17269124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of protein--DNA interactions using surface plasmon resonance spectroscopy with various assay schemes.
    Teh HF; Peh WY; Su X; Thomsen JS
    Biochemistry; 2007 Feb; 46(8):2127-35. PubMed ID: 17266332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
    Kostelac D; Rechkemmer G; Briviba K
    J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold-nanoparticle-based assay for instantaneous detection of nuclear hormone receptor-response elements interactions.
    Tan YN; Su X; Liu ET; Thomsen JS
    Anal Chem; 2010 Apr; 82(7):2759-65. PubMed ID: 20199029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
    Wolohan P; Reichert DE
    J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
    Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation-prone positions within the estrogen receptor.
    Wiwanitkit V
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):130-2. PubMed ID: 19574173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of an estrogen receptor mutant with altered DNA-binding specificity.
    Nguyen D; Bail M; Pesant G; Dupont VN; Rouault E; DeschĂȘnes J; Rocha W; Melançon G; Steinberg SV; Mader S
    Nucleic Acids Res; 2007; 35(10):3465-77. PubMed ID: 17478511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of estrogen receptor-beta selective ligands.
    Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
    J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
    Burendahl S; Danciulescu C; Nilsson L
    Proteins; 2009 Dec; 77(4):842-56. PubMed ID: 19626711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the human estrogen receptor-alpha using targeted mutagenesis.
    Skafar DF; Koide S
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):83-90. PubMed ID: 16442702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulation in solvent of the estrogen receptor protein DNA binding domain in complex with a non-consensus estrogen response element DNA sequence.
    Harris LF; Sullivan MR; Popken-Harris PD
    J Biomol Struct Dyn; 1997 Dec; 15(3):407-30. PubMed ID: 9439992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of flexibility and stability in the control of estrogen receptor activity.
    Bouter A; Le Tilly V; Sire O
    Biochemistry; 2005 Jan; 44(2):790-8. PubMed ID: 15641807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, thermodynamics and cooperativity of the glucocorticoid receptor DNA-binding domain in complex with different response elements. Molecular dynamics simulation and free energy perturbation studies.
    Eriksson MA; Nilsson L
    J Mol Biol; 1995 Oct; 253(3):453-72. PubMed ID: 7473727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
    J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomy of the estrogen response element.
    Gruber CJ; Gruber DM; Gruber IM; Wieser F; Huber JC
    Trends Endocrinol Metab; 2004 Mar; 15(2):73-8. PubMed ID: 15036253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNA binding domain of estrogen receptor alpha is required for high-affinity nuclear interaction induced by estradiol.
    Weinberg AL; Carter D; Ahonen M; Alarid ET; Murdoch FE; Fritsch MK
    Biochemistry; 2007 Aug; 46(31):8933-42. PubMed ID: 17630774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bending of the estrogen response element by polyamines and estrogen receptors alpha and beta: a fluorescence resonance energy transfer study.
    Vijayanathan V; Thomas TJ; Nair SK; Shirahata A; Gallo MA; Thomas T
    Int J Biochem Cell Biol; 2006; 38(7):1191-1206. PubMed ID: 16767802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.